Medicinal Mushrooms & Mental Health (Adult Population)

The CNP Medicinal Mushrooms & Mental Health Research Category consolidates research exploring the interconnected relationship between medicinal mushrooms and mental health. Cassidy Axelrod is CNP's Medicinal Mushrooms and Mental Health contributor and is the lead developer of this research category. To view each original study on the open internet, click “Original.” To view the CNP-written abstract summary, click “CNP Summary.” While only some of the CNP-written abstract summaries are available below for free, all abstract summaries are available to CNP members through the CNP Library Membership.

CNP Library Membership

FEATURED CNP RESEARCH SUMMARY

Neurohealth properties of Hericium erinaceus Mycelia enriched with Erinacines

This 2018 review takes a closer look at erinacine A, the only active compound in Hericium erinaceus that has shown pharmacological activity in the central nervous system in rats. Hericium erinaceus is an edible and medicinal mushroom capable of promoting positive brain and nerve activity. The aim of this review was to summarize the available data on the neurohealth properties of H. erinaceus mycelia enriched with erinacines. The information covered here may contribute to future research evaluating the therapeutic roles of these mycelia. Furthermore, Li et al. discusses the safety of consuming these medicinal mushrooms. It may be challenging to translate the results of in vivo studies into clinical situations, but the inclusion of H. erinaceus mycelia enriched with erinacines in daily meals has demonstrated the ability to improve cases of depression, ischemic stroke, Parkinson's disease, and Alzheimer's disease.

RESEARCH SUMMARIES

CNS anti-depressant, anxiolytic and analgesic effects of ganoderma applanatum (mushroom) along with ligand-receptor binding screening provide new insights: Multi- disciplinary approaches

Antidepressant-like effects of a water-soluble extract from the culture medium of Ganoderma lucidum mycelia in rats